Osteoporosis Trial, Recruiting NCT07030205 Sponsor: University Hospital, Clermont-Ferrand Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT07030205
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with osteoporosis:

  • Women aged 50 or older who have been diagnosed with postmenopausal osteoporosis by a rheumatologist, whether or not they have had a fracture
  • People who are able to give their consent to take part in the research
  • People who are affiliated with French Social Security

For healthy volunteers:

  • Women aged 50 or older who do not have osteoporosis, as confirmed by a bone density scan reviewed by the trial investigators
  • People whose age, menopausal status, education level, and hand preference (left or right) are matched to those of the patients in the trial
  • People who are able to give their consent to take part in the research
  • People who are affiliated with French Social Security
  • People who are registered, or willing to be registered, in the national register of volunteers participating in research

Who may not be able to join:

  • People who have a pacemaker or wear a hearing aid
  • People who have any implants, prostheses, or other medical devices in their body
  • People who have claustrophobia (fear of enclosed spaces)
  • People who wear a brain clip (a surgical clip used in the brain)
  • People whose situation is incompatible with the safety requirements of the MRI scanning centre for 3 Tesla magnetic resonance imaging (confirm with trial site)
  • People who are not willing to be told if something unexpected is found in their brain scan during the study
  • People who are under legal protection or who are not free to make their own decisions (such as those deprived of liberty)
  • People who do not wish to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marie-Eva Pickering, University Hospital, Clermont-Ferrand

Phone: 334.73.754.963

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 September 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Functional connectivity value of brain networks at rest

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov